About US
Contact us
-
UPDATED: Gilead snags FDA approval for improved hep B drug VemlidyGilead Sciences, whose hepatitis C dynasty has been slipping, haswon approvalfor its next-gen hepatitis B treatment. The Foster City, CA-based drugmaker said Thursday that the FDA had approvedVemlidy2016/11/24
-
GSK files regulatory submission with US FDA for FF / UMEC / VI therapyGlaxoSmithKline (GSK) and Innoviva have filed a regulatory submission with the US Food and Drug Administration (FDA) for fluticasone furoate / umeclidinium / vilanterol (FF / UMEC / VI 100mcg / 62.5mc2016/11/23
-
Novartis acquires Selexys Pharmaceuticals in US for $665mNovartis has acquired US-based hematologic and inflammatory disorder theraputics developer Selexys Pharmaceuticals in a deal valued at approximately $665m. The company exercised its acquisition right2016/11/23
-
Russian Federation set to introduce new scientific drug research projectsThe Russian Federation’s Industry and Trade Ministry is set to introduce the latest scientific research on drugs, with an aim to help innovative developments enter Russia and western markets. As part2016/11/22
-
AstraZeneca’s MedImmune completes licensing agreement with Allergan for MEDI2070British drugmaker AstraZeneca’s global biologics research and development arm MedImmune has completed a licensing agreement with Allergan for the global rights to IL-23 monoclonal antibody MEDI2070.2016/11/22
-
Eli Lilly secures conditional marketing authorisation for olaratumab injection with doxorubicinThe European Commission (EC) has granted conditional marketing authorisation for Eli Lilly and Company’s (LLY) olaratumab injection of 10mg/ml in combination with doxorubicin, to treat adults with adv2016/11/21
-
Report: Novel pipeline products to drive schizophrenia market growthThe schizophrenia market is projected to increase from $6.4bn in 2015 to $7.3bn by 2025 at a compound annual growth rate of 1.4%, according to a report by GlobalData. Titled 'PharmaPoint: Schizophren2016/11/21
-
M&As this week: CiToxLAB, Sichuan Kelun PharmaFrench-based pre-clinical services providerCiToxLAB Grouphas announced that it has acquired a pre-clinical contract research company known as AccelLAB. "The acquisition is expected to foster the acqu2016/11/18
-
Deals this week: Incyte Corporation, Orexigen Therapeutics Ireland, Mitsubishi Tanabe Pharma CorporationUS-based biopharmaceutical companyIncyte Corporationhas entered a distribution agreement for the commercialisation of its drug named Iclusig (ponatinib) in Greece with GENESIS Pharma. The agreement w2016/11/18
-
Haiti launches cholera vaccination campaignHaiti has launched an emergency cholera vaccination campaign, under which more than 800,000 affected by Hurricane Matthew last month will be vaccinated. After the category-four storm devastated south2016/11/17